(Q42463148)

1 November 2017

Interspecies differences in the nephrotoxic response to cyclooxygenase inhibition (English)

1 reference

1 November 2017

Rani S Sellers

1

1 reference

1 November 2017

Peter B Senese

series ordinal

2

1 reference

1 November 2017

K Nasir Khan

series ordinal

3

1 reference

1 November 2017

language of work or name

1 reference

1 May 2004

1 reference

Drug and Chemical Toxicology

1 November 2017

1 reference

1 November 2017

27

1 reference

1 November 2017

111-122

1 reference

1 November 2017

2

1 reference

Renal effects of cyclooxygyenase-2-selective inhibitors

1 November 2017

1 reference

https://api.crossref.org/works/10.1081%2FDCT-120030726

21 January 2018

Renal papillary necrosis

1 reference

https://api.crossref.org/works/10.1081%2FDCT-120030726

Renal arachidonic acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDCT-120030726

The coxibs, selective inhibitors of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDCT-120030726

Suppression of plasma renin activity by indomethacin in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDCT-120030726

Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDCT-120030726

Prostaglandin synthase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDCT-120030726

Physiologic characteristics and clinical importance of the cyclooxygenase isoforms in dogs and cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDCT-120030726

Cyclooxygenase-2 expression in the developing human kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDCT-120030726

Pharmacology of cyclooxygenase-2 inhibition in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDCT-120030726

Renal changes associated with naproxen sodium administration in cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDCT-120030726

Functions of the renin-angiotensin system during development

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDCT-120030726

Effects of inhibition of prostaglandin synthesis on fetal renal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDCT-120030726

Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDCT-120030726

Prostaglandin endoperoxide synthases-1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDCT-120030726

Role of cyclooxygenase-2 in the prolonged regulation of renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDCT-120030726

Persistent anuria, neonatal death, and renal microcystic lesions after prenatal exposure to indomethacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDCT-120030726

Nonsteroidal anti-inflammatory drugs: effects on kidney function

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDCT-120030726

Effect of papillotoxic agents on expression of cyclooxygenase isoforms in the rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDCT-120030726

Arachidonic acid increases and indomethacin decreases plasma renin activity in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDCT-120030726

Immunolocalization of cyclooxygenase-2 in the macula densa of human elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDCT-120030726

21 January 2018

Identifiers

DOI

10.1081/DCT-120030726

1 reference

1 November 2017

1 reference